EUVIMEDEUVIMED entdecken
Crossref

Successful novel use of low-dose sirolimus for treatment-refractory cutaneous sarcoidosis

Lachlan D W Lau iD, Yonatan Kok, Malindi G Haggett, Laura Scardamaglia

Clinical and Experimental Dermatology · 17.08.2026 · 51 (9) · 1737-1740

DOI: 10.1093/ced/llag182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 24.04.2026. Verfasst von Lachlan D W Lau und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Western Health, St Albans, VIC, Australia. Die Arbeit nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 68-year-old woman with longstanding multisystem sarcoidosis and a 20-year history of cutaneous disease refractory to multiple immunomodulatory treatments experienced rapid symptomatic improvement and near-complete clearance of skin lesions within 5 months of starting adjunctive low-dose oral sirolimus 0.5 mg daily, with no observed adverse effects. While this case adds to emerging observations of sirolimus’ potential effectiveness in refractory cutaneous sarcoidosis, the findings are exploratory and further studies are warranted to establish the safety, efficacy and appropriate role of low-dose sirolimus in the management of refractory cutaneous sarcoidosis.

Autor:innen und Institutionen

  • Department of Dermatology, Western Health, St Albans, VIC, Australia.
  • Department of Dermatology, Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Department of Medicine, University of Melbourne, Parkville, VIC, Australia.

ORCID-Profile: Lachlan D W Lau

Zitieren

APA

Lau, L. D. W., Kok, Y., Haggett, M. G., & Scardamaglia, L. (2026). Successful novel use of low-dose sirolimus for treatment-refractory cutaneous sarcoidosis. Clinical and Experimental Dermatology, 51(9), 1737-1740. https://doi.org/10.1093/ced/llag182

Vancouver

Lau LDW, Kok Y, Haggett MG, Scardamaglia L. Successful novel use of low-dose sirolimus for treatment-refractory cutaneous sarcoidosis. Clinical and Experimental Dermatology. 2026;51(9):1737-1740. doi:10.1093/ced/llag182

BibTeX
@article{Lau2026,
  author = {Lau, Lachlan D W and Kok, Yonatan and Haggett, Malindi G and Scardamaglia, Laura},
  title = {Successful novel use of low-dose sirolimus for treatment-refractory cutaneous sarcoidosis},
  journal = {Clinical and Experimental Dermatology},
  year = {2026},
  volume = {51},
  number = {9},
  pages = {1737--1740},
  doi = {10.1093/ced/llag182}
}
Kostenlos starten →